Ensuring Quality Consistency: Thermo Fisher Scientific's Global Commitment To Quality

For biopharmaceutical developers pursuing global commercialization, regulatory quality requirements across the FDA, EMA, and NMPA don't simply vary in scope; their implementation and enforcement differ in ways that can meaningfully complicate manufacturing partnerships and market access strategies. Achieving consistent quality across a global CDMO network requires more than site-level compliance. It requires a unified framework where standards, tools, and governance structures operate the same way regardless of geography.

This brochure details a quality management approach built around the concept of quality management maturity, including how site-specific performance plans, globally tracked risk monitoring, and a reporting structure that elevates site quality directors above local site management contribute to consistency at scale. Metrics like a 95% Right First Time rate and more than 2,600 successful regulatory and client inspections since 2005 provide context for how the framework performs in practice.

Examine the full brochure to understand the framework in detail.